Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06189079
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-11-30
Brief Title:
Arterial Embolization for the Treatment of Bone Metastases Prospective Observational Study
Sponsor:
Istituto Ortopedico Rizzoli
Organization:
Istituto Ortopedico Rizzoli
Study Overview
Official Title:
Embolizzazione Arteriosa Per il Trattamento Delle Metastasi Ossee Studio Osservazionale Prospettico
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EMBONEMET
Brief Summary:
To date arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases allowing good results in terms of pain reduction local control of disease and reduction of peri-operative bleeding with low invasiveness
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None